Starton Therapeutics Successfully Demonstrates Continuous Drug Delivery of Lenalidomide from a…
STAR-LLD is believed to be the first continuously delivered immunomodulatory imide drug (IMiD) in development to expand the use of lenalidomide in multiple myeloma and become the first IMiD for CLLStarton has shown unprecedented efficacy…